Nyxoah Stock Wiped Out 70% in 2026 as Sleep Apnea Device Sales Fail to Stem Losses
Companies

Nyxoah Stock Wiped Out 70% in 2026 as Sleep Apnea Device Sales Fail to Stem Losses

Shares of the Genio neurostimulation maker have collapsed to €1.21 this year, despite rising revenue, with the market pr...

Declan Byrne 👁 32 💬 0
European Equities Snapshot: 30 Gainers Against 20 Decliners as Large Caps Edge Higher
Markets

European Equities Snapshot: 30 Gainers Against 20 Decliners as Large Caps Edge Higher

A 50-line European price feed shows more advancers than decliners but a broadly flat average move, with the largest quot...

Yael Ben-David 👁 32 💬 0